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ABSTRACT
Objective: To investigate the association between Primary Open Angle Glaucoma 
(POAG), Intraocular Pressure (IOP) and systemic hypertension. 
Design: Cross-sectional, convenient and controlled study. 
Setting: Eye Clinic of the Lagos University Teaching hospital, Idi-Araba, Lagos, 
Nigeria. 
Subjects: Consecutive new patients with documented history of hypertension medication 
of over three months and current attendees at hypertension clinic of the same hospital 
were enrolled into the study. 
Results: A total of 150 hypertensive patients and 50 age-sex matched controls were 
studied. Age range of hypertensives was 34-54 years and controls 31-71 years. The 
mean age for hypertensive group was 56 years (±12.95) and controls 54.76 years (±9.65) 
p>0.1. The mean IOP was 28.45mmHg (±10.3) in hypertensive group and 15.2mmHg 
(±5.09) in controls (P<0.001). POAG was present in 58 (38.7%) of the hypertensive 
patients whilst only nine (18.0%) had POAG in control group (p<0.01 odds ratio: 22). 
lOP> 21mmHg was found in 28 (18.7)) of hypertensive group and two (4.0%) of the 
control (p<0.01 odds ratio 4.7). 
Conclusion: Systemic hypertension showed a modest positive association with elevated 
intraocular pressure. The strong relationship with IOP in part supports the association 
with POAG. 
INTRODUCTION
Primary Open Angle Glaucoma (POAG) and 
systemic hypertension are diseases of public health 
importance contributing immensely to the burden 
of blindness, ill health and mortality in our country 
Nigeria and Worldwide (1-5). 
 Both disease conditions demonstrate 
similar epidemiological characteristics some of 
which are; higher prevalence with advancing 
age (4-6) increase prevalence with exponential 
increase in population ageing (5,6), and almost 
a quarter to half of the affected individuals not 
aware that they suffer from the disease (4,7). 
The clinical course of both conditions is more 
aggressive in blacks than, in Caucasians (8). 
Elevated Intraocular Pressure (IOP) has been 
proven by many studies as a major risk factor 
for the development of POAG (7,9). 
Systemic hypertension is a well recognised 
risk factor for elevated lOP and several studies have 
shown a consistent association between elevated 
IOP and rise in systolic blood pressure and fewer 
with diastolic pressure (10-12). 
POAG is the second common cause of 
blindness globally and in the South West Nigeria with 
a prevalence of 2-10% in individuals of over 40 years 
of age (l, 13-15).   Systemic hypertension accounted 
for 20% of all cause mortality in blacks compared to 
10% in whites with a gradient in its prevalence across 
African Diasporas ranging from 16%) in West Africa 
to 26% in the Caribbean and 33% in the United States 
of America (16). 
An evaluation of the impact of systemic 
hypertension on IOP and the incidence of POAG 
in these groups of patients is quite relevant in our 
environment as there has been no known report on 
the association in Nigerians. 
Our study was designed to examine the 
relationship between systemic hypertension, 
intraocular pressure and primary open angle 
glaucoma in Nigeria. 
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MATERIALS AND METHODS
Consecutive new patients at the Eye Clinic of Lagos 
University Teaching Hospital, Idi-Araba, with 
documented history of hypertension and/or use of 
antihypertensive medication of over three months 
and current attendees at hypertension clinic of the 
same hospital without previous ocular disorders 
between April-July 2004 were enrolled into the 
study. Age-sex matched non-hypertensive patients 
formed the control group. 
POAG was defined by the presence of 
a demonstrable glaucomatous optic nerve head 
damage based on visual field and/ or optic 
disc findings.  Elevated IOP was defined by 
IOP>21mmHg. Systemic hypertension was defined 
by self reported Physician diagnosis or from systolic 
blood pressure >140/90mmHg and or treatment 
history of three months or more. 
Out of convenience the three investigators 
studied ten patients per clinic day culminating in a 
study period of four months. 
All participants had detailed examination 
done according to standard protocols by the three 
authors between 9:00am-12noon at each visit in 
their respective clinics. 
Assessment included: 
(i) Detailed medical history interview
(ii) lOP measurements with Perkins hand held 
applanation Tonometer taking an average of 
two readings by the first author 
(iii) Dilated bionocular Fundoscopy with +78D 
assessment of optic nerve head with slit lamp 
by the first author. 
(iv) Gonioscopy 
(v) Blood pressure  measurement  with 
standardised mercury sphygmomanometer 
by the second author. 
Excluded were patients with 
(i) Known POAG patients currently on 
treatment 
(ii) Family history of POAG 
(iii) Myopia 
(iv) Diabetes mellitus 
(v) Previous ocular trauma or diseases other than 
POAG. 
 Informed consent was obtained from all patients. 
Data analysis was done with Epi Info 2002. 
RESULTS
A total of 150 patients with systemic hypertension 
and 50 normotensive age-sex matched controls were 
studied. The socio-demographic characteristics 
are shown in Table 1. The mean (±SD) age of 
hypertensive patients was 56.7 ± 12.95 years (range 
34-84). The mean (±SD) age for control group 
was 54.7 ± 9.65 years (range 31-71). There was no 
significant difference in the mean age of the two 
groups p>0.1. Male to female ratio was 1:1.3 and 
1:1 for hypertensive and control group respectively. 
The mean (±SD) IOP for the hypertensive group was 
28.4 ± 10.3mmHg (range 10-49mmHg) and control 
was 15.2 ± 5.09mmHg (range 8-25mmHg). There 
was a highly significant difference with p<0.00l in 
the mean IOP of the two groups. The mean IOP 
in the hypertensive group was remarkably high. 
Only one hypertensive patient was on ß-adrenergic 
blocker for control of hypertension. 
IOP>21 mmHg was found in 28 (18.7%) 
of hypertensives and in only two (4.0%) of the 
normotensive patients (p<0.0l). The relative risk of 
elevated IOP in hypertensive individual is higher 
with an odds ratio of 4.7 at 951%<, CI (Table 2). 
Table 3 shows the association between 
the frequency of POAG in patients with systemic 
hypertension and normotensive individuals. POAG 
was found in 58 (38.7%) of hypertensive patients 
and in nine (18.0%) of normotensive individuals 
(p<0.0l). There is a significant different between the 
two groups. Individuals with systemic hypertension 
are at a risk of developing POAG with an odds ratio 
of 2:2. 
Table 1 
Socio-demographic characteristics of patients 
                  Hypertensives (n = 150)                    Controls (n = 50)
Age group (years)   No. (%)  No.  (%) 
31-40  12 8  6  12 
41-50  30  20  13  26 
51-60  58 38.7  14  28 
61-70  39  26  16  32 
>71  11  7.3  1  2 
Total  150  100  50  100 
Age range 34-84 years  31-71 years  
Mean age 56.7 years(± 12.95) 54.7 years (±9.65) p>0.l 
Sex  Cases  (%)  Controls  (%)
Male  66  44  25  50 
Female  84  56  25  50 
Ratio  1:1.3   1:1 
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DISCUSSION
The results of our study are indicative of a positive 
association between elevated IOP with the presence 
of POAG in patients with systemic hypertension. 
Elevated IOP mean >21mmgH was found 
in 18.7% of patients with systemic hypertension 
compared to 4.0% in controls (p<0.01 odds ratio 4.7) 
(Table 2). Individuals with systemic hypertension 
are therefore 4.7 times more at risk of developing 
elevated IOP than normotensive individuals. 
Wu et al (10), Bengtsson (11), Bulpitt et al (12), 
and Shiose et al (17) in their studies on relationship 
between systemic hypertension and IOP found 
similar results. The possible mechanism is thought 
to be due the increased systemic blood pressure 
leading to increased production of aqueous humour 
by means of elevated ciliary artery pressure (12,17). 
Another pathway is thought to emanate from the 
increased sympathetic tone in the vessels and the 
role of serum glucocorticoids (18-20). 
 In the Beaver Dam Eye study a significant 
correlation was found between changes in systemic 
blood pressure and changes in IOP, reduced 
systemic blood pressure was found associated with 
reduction of intraocular pressure (21). 
The positive association could also be 
linked to the common pathogenefic mechanism at 
ciliary and renal tubular epithelial cells with regards 
to handling of sodium (Na+) excretion (20). Sodium 
is the primary promoter of body fluid and hence 
blood volume and cardiac output. Reduction in its 
excretion expands the extracellular fluid volume 
resulting in increase in cardiac output and therefore 
the blood pressure (22). Poor handling of Na+ at 
the ciliary epithelial cells could lead to increase 
in intraocular pressure as a result of the volume 
expansion of the aqueous humour stemming from 
increased affinity for water. 
POAG (high and normal tension) was 
detected in 38.7% of systemic hypertensives 
compared to 18.0% of age-sex adjusted controls with 
odds ratio of 2.2 (p<0.0l) (Table 3). Individuals with 
systemic hypertension are two times more likely to 
develop POAG than normotensive individuals. 
Several population studies have confirmed 
these associations between systemic hypertension 
and POAG (19-24). Elevated IOP which is a known 
risk factor for developing POAG being positively 
associated with systemic hypertension is a major 
influence on the increased association. 
Other reasons for the positive association of 
POAG and systemic hypertension could be adduced 
to the reduced optic nerve head and choroidal 
perfusion resulting from a decreased mean blood 
volume velocity in systemic hypertension, coupled 
with nocturnal dips (hypotension) experienced 
by those on antihypertensive treatments (25,26). 
Vascular dysregulation with resultant hypotension 
at night is also an important predisposing factor 
contributing to the increased prevalence in patients 
with systemic hypertension (26,27). 
The positive relationship is also further 
supported by the common pathogenetic mechanism 
with altered sodium transportation at distal nephron 
and ciliary epithelial cells (20). 
The similar epidemiological characterisics 
demonstrated by POAG and systemic hypertension 
Table 2 
Associations between elevated lOP and systemic hypertension
Risk factor  IOP >21 mmhg IOP<21 mmhg  Total 
Hypertension( +) 28 122 150
Hypertension(-)  2 48 50
Total  30 170 200
P<0.0l 
Relative risk (odds ratio) 4.7 
Table 3 
Association between systemic hypertension and POAG 
Risk factor  POAG(+)  POAG(-)  Total 
Hypertension (+)  58  92  150 
Hypertension (-)  9  41  50 
Total  67  133  200 
P<0.01
Relative risk (odds ratio) 2.2 
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further strengthens a possible link in their 
pathogenic pathways (4-7). Systemic hypertension 
is often a component of Syndrome X(metabolic 
syndrome) composed of dyslipidaemia, impaired 
glucose tolerance, diabetes mellitus and abdominal 
obesity (5). Girkin (25) et al in his study found that 
glaucoma patients had significantly higher rates of 
diabetes, lipid metabolism disorders, hypertension 
and migraines than controls. These associations 
could serve as a link to discovering the aetiology 
in primary open angle glaucoma. The question in 
mind is “Is glaucoma a component of metabolic 
syndrome?” A recent study done in South Korea 
to link elevated intraocular pressure and metabolic 
syndrome/insulin resistance revealed a higher 
level of mean intraocular pressures in participants 
with metabolic syndrome compared to those who 
did not have metabolic syndrome (29). The mean 
IOP tended to increase linearly with the presence 
of increasing numbers of components for metabolic 
syndrome (29). There is evidence of presence of 
insulin like growth factor 1 (IGF 1) receptor cells in 
bovine trabecular meshwork (30). It is thought that 
an abnormal down-regulation in IGF1 production 
may contribute to the pathogenesis of POAG. A 
possibility of promoting the autocrine action of IGF1 
by trabecular meshwork cells to treat the disease is 
worth further investigation (30). 
Further research at molecular level to link 
insulin resistance with POAG may give the desired 
answer to the aetiology and possibly a cure that has 
been most sought after in the treatment of POAG. 
The study has also clearly demonstrated 
the need to critically screen every patient with 
systemic hypertension for POAG and subsequently 
reduce the ocular morbidity from the disease. The 
prominent role played by poor Na+ excretion in 
pathogenesis of systemic hypertension may also set 
off a line of thought on the effect of salt consumption 
on the level of IOP and subsequently on open angle 
glaucoma. 
However, our study having too few 
controls compared to cases (1:3) may not have given 
an accurate result representative of the reference 
population. Being a hospital based study, made it 
difficult to get many non-hypertensive patients in 
the studied age group visiting the hospital. Another 
limitation was the failure to take into consideration 
the current antihypertensive drugs the patients were 
on. It is known that patients using (ß adrenergic 
blockers as their antihypertensive have better 
control of IOP and disease progression than others 
on Angiotensin Converting Enzyme inhibitors and 
Calcium channel blockers (20). This may be due to 
the natriuetic and channel blocking effect of the B 
blocker thereby leading to a reduction of the toxic 
effect of the extracellular Na+ on the axons of retinal 
ganglion cells (31,32). In our study only one patient 
was on ß blocker for control of hypertension and 
was eliminated from analysis. This is however not 
surprising, as most of the hypertensive patients in 
our environment rarely used (ß-adrenergic blockers 
for control of hypertension (29), as evidenced by a 
study done by Alebiosu in a similar tertiary health 
institution in South West of Nigeria. 
A larger population based study with 
a higher proportion of controls; taking into 
consideration the current antihypertensive the 
patient is using in our environment is therefore 
required for a clear and concise demonstration of 
the relationship. 
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